President of National Cosmetic Dermatology Organization Urges Consumers to
Beware!
OMAHA, Neb., Sept. 24 /PRNewswire/ -- Joel Schlessinger, M.D., President of the American Society of Cosmetic Dermatology and Aesthetic Surgery (ASCDAS), responded to the recent decision by Judge David Bruns to block the proposal by the Kansas State Board of Healing Arts to ban the liposuction treatment, Lipodissolve. "This procedure is still unsafe in my estimation and has the potential to cause significant harm, especially given its poor track record in Europe, Brazil and Canada," the board-certified dermatologist and general cosmetic surgeon said.
The safety of Lipodissolve, a treatment involving a series of injections of a mixture of phosphatidylcholine and sodium deoxycholate (PC/DC) to break down body fat, has long been criticized as unstudied by medical entities. In addition to Schlessinger's statement on behalf of ASCDAS, the American Society of Plastic Surgeons and the American Society of Dermatologic Surgeons have also released statements against the use and practice of Lipodissolve. The proposed ban by the Kansas State Board of Healing Arts was the first of its kind in the United States, and followed the lead of Brazil, Canada and the United Kingdom in banning Lipodissolve treatments. "The decision to reverse the Kansas block on Lipodissolve unfortunately goes against FDA statements regarding the safe and responsible practices of cosmetic dermatology," states Schlessinger.
"I am quite concerned that this process is going on in a wide variety
of unregulated settings. Many cases have come to my attention where
patients suffered long-term consequences, most of the time without having
any idea of the potential for problems prior to having treatments
performed" said Joel Schlessinger M.D. "Additionally, the individuals
administering the procedure are frequently unskilled in sterile technique,
the ingredients used in the t
'/>"/>
| SOURCE Joel Schlessinger, M.D. Copyright©2007 PR Newswire. All rights reserved |